Concepedia

Colin Molloy

CM

Statistics

Publications

13

Citations

1.7K

H-Index

13

Active since

2005

Affiliations

University of Glasgow(Current)

Monash University

University of Leicester

University of Nottingham

University of Cambridge

Colin Molloy is an author at University of Glasgow specializing in medicine, neurology, and neuropharmacology.

ORCID

Top concepts

Publications per year

2005–2022

13

Publications

13

Oral Treatment Targeting the Unfolded Protein Response Prevents Neurodegeneration and Clinical Disease in Prion-Infected Mice

Julie A. Moreno, Mark Halliday, Colin Molloy et al. · Science Translational Medicine · 2013 · 566 citations

, , +18

Repurposed drugs targeting eIF2α-P-mediated translational repression prevent neurodegeneration in mice

Mark Halliday, Helois Radford, Karlijn A. M. Zents et al. · Brain · 2017 · 288 citations · Full text

RBM3 mediates structural plasticity and protective effects of cooling in neurodegeneration

Diego Peretti, Amandine Bastide, Helois Radford et al. · Nature · 2015 · 242 citations · Full text

DREADD Agonist 21 Is an Effective Agonist for Muscarinic-Based DREADDs<i>in Vitro</i>and<i>in Vivo</i>

Karen Thompson, Elham Khajehali, Sophie J. Bradley et al. · ACS Pharmacology & Translational Science · 2018 · 185 citations · Full text

From structure to clinic: Design of a muscarinic M1 receptor agonist with the potential to treat Alzheimer’s disease

Alastair Brown, Sophie J. Bradley, Fiona H. Marshall et al. · Cell · 2021 · 87 citations · Full text

, , +10

Rows per page

1–5 of 13